Editor's Choice
iPhone sales fuel smartphone surge
Apple became the world's largest smartphone vendor in the fourth quarter of 2011 in a bumper season for higher margin phones, according to the market research firm Gartner. Video
Debate recap: Bird Flu Research
Dangerous information on a deadly virus
A call to censor scientific research on the deadly bird flu virus has global health officials debating whether such studies are worth the risk. Read our recap of a Harvard School of Public Health discussion on this subject, presented in collaboration with Reuters. Learn More
Nasal spray may trigger migraine
NEW YORK |
NEW YORK (Reuters Health) - People with hay fever -- more accurately termed allergic rhinitis -- may find themselves with a migraine after they use a nasal steroid spray to relieve their stuffy noses.
Dr. Jitka Pokladnikova, of Charles University in Prague, and colleagues reviewed the World Health Organization's global database and other sources and found an unexpected cluster of 38 cases of migraine suspected to be related to the use of intranasal corticosteroids.
The suspected intranasal corticosteroids included six different drugs: fluticasone, beclomethasone, budesonide, mometasone, flunisolide, and triamcinolone. In 24 cases the intranasal corticosteroid was the only drug used, the researchers report in the medical journal Cephalalgia.
Re-exposure to the intranasal corticosteroid led to a relapse of migraine in eight patients. None of the drugs exceeded the maximum daily recommended dose range in any reported case.
In the 16 reports where time to onset was recorded, migraine developed early in the course of intranasal corticosteroid treatment in 12 cases -- within the first four days.
A connection between allergic rhinitis and migraine has already been established. The new findings suggest that, "in addition, intranasal corticosteroids might cause or worsen migraine or migraine-like headache," Pokladnikova and colleagues conclude.
SOURCE: Cephalalgia, March 2009.
- Tweet this
- Link this
- Share this
- Digg this
- Reprints





Follow Reuters